Patient organizations and their role in drug development or clinical research

\r\n Rare disease drug development could benefit substantially from increased patient engagement and input to enhance understanding of the key aspects of disease impact, ways to measure these impacts and patients' perspectives on the benefit-risk profile of potential therapies.

\r\n

    Related Conference of Patient organizations and their role in drug development or clinical research

    February 24-25, 2020

    7th International Congress on Infectious Diseases

    Berlin, Germany
    April 27-28, 2020

    7th Global Congress on Rare Diseases & Orphan Drug

    Istanbul, Turkey
    June 09-10, 2020

    10th European Epidemiology and Public Health Congress

    Istanbul, Turkey
    July 22-23, 2020

    10th World Congress on Rare Diseases and Orphan Drugs

    Barcelona, Spain
    August 19-20, 2020

    European Summit on HIV, STD and STIs

    Milan, Italy
    September 28-29, 2020

    13th Global Infections Conference

    Singapore
    September 28-29, 2020

    World Congress on Infectious Diseases and Rare Diseases

    Osaka, Japan
    October 5-6, 2020

    12th Euro-Global Conference on Infectious Diseases

    Vienna, Austria
    November 25-26, 2020

    Intercontinental Conference on Infectious Diseases

    Tokyo, Japan

    Patient organizations and their role in drug development or clinical research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in